Colesevelam (Welchol) For Hypercholesterolemia
Colesevelam hydrochloride (Welchol - Sankyo Pharma), a nonabsorbed hydrophilic polymer that binds bile acids, has been approved by the FDA for reduction of plasma LDL cholesterol in patients with primary hypercholesterolemia....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Colesevelam (Welchol) For Hypercholesterolemia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1091
Article Code: 1091b
Date: October 30, 2000
Volume: 42
Pages: 102-104
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1091
Article Code: 1091b
Date: October 30, 2000
Volume: 42
Pages: 102-104
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)